{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"thiamine-responsive-megaloblastic-anemia","columns":[{"gene":"","key":"population-181c482cfd8c7283975e","label":"Thiamine-Responsive megaloblastic anemia syndrome","mondoId":"MONDO:0009575","onsetQualifier":null,"originColumnKey":"MONDO:0009575/OMIM:249270","originalViews":[{"key":"MONDO:0009575/OMIM:249270","label":"Thiamine-Responsive megaloblastic anemia syndrome","scopeLabel":"OMIM:249270","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["02cc368270d114d5138eeed135628f794088d8e2cfcb47e9cfa0d49779cf339e","08de078933bdc55458a682aa25087ecb8dc98c801915485bf358729b5d05beb4","0b3aa54afc161b307cce11547e23653ea3b44b81e1db38d9bc19dc01a9fb8aa0","2e2399d076fceb0b6de7c51e361db5e74b3602c3ee8f868be03715fc2687d918","4199d3e33258f36b6b7c0aa8ff50663595b07a48ba3b3c639e8aec60dcf48b7c","517a15d9675c25dfdf83f83f8f2d7505ad68266398eab48fdc4a2f26630ceb38","5717037e59ede80f457ed2dec33ea8037eaaf67c7b57cd98d45fd645c8721382","596583379fdf929cd558852e295ddc1655171c3158e78ce4c233932734a015c1","6d15e2cba635fc179f9c61721e08a18f9865646cd3f190f806a47b7c62e55d41","7e1be44564fd7c59984c22bd4c89179c5724583155798b7fde5d7a0335637d0e","88003a0f51884e120a8fdc1c06906c71267d479d8315ef1cb961269fa9c607e8","8b3ff74793e75403d817c5cc33d1900bfeeaac8ada073704595cd9c9068ef6fa","995d7fb19973de4165c0608ca09517f2c4e80977119f894c4d4faf1a11dd07d2","9a5e716c827828c5aa94dd3b4bcd6f64b3e70ca7130ff80c99b34172a6253716","9cb291f403a2cc921ab2278844ac471edb3bc20666d068607d818ebcf663e419","b1ec2921e07ff4fa3436a326061e130a4787c665e320aa29263c952523eaf49d","b6364380e06314232187a0670c597479ab28ca9c9ddfe4d3bbe841383c306bf8","bda78c4be3dbd27d00bd233eb29d0c5e594e28fbb22257ff82b6b804400a3134","cd6234c8b39b1b6cf842c598767c7fa88c6c9c683d3c67a1527fa61080dd33d2","d8de297a6603083c6c176b373da825590d9f5d7dcf51011e6918f1d129c25ecc","e32ceeb914244b320a11e77700dc2aad8fb6f830f0faa7af70534da095b3428c","f58f1dbf44bbf760aa971440c29be59ae0b84eef6455ffb93cc746aaa0adeded","f637ad29780f6035f211ce17a2b3ccbe515559a52fb935f92181815736015f2c","f66412a9c94f73d6fa3368c7bd66c2ce08bcff07711aef6ec0b21be68c962953","f763d1f3913469e15ca28cbc9a7adbada1a71dc9c6a52ccd75209a5f51ec590e"],"recordQualifiers":{},"scopeLabel":"OMIM:249270","sourceIds":["OMIM:249270"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-4317a783606bea20ef34","label":"Thiamine-responsive megaloblastic anemia syndrome","mondoId":"MONDO:0009575","onsetQualifier":null,"originColumnKey":"MONDO:0009575/ORPHA:49827","originalViews":[{"key":"MONDO:0009575/ORPHA:49827","label":"Thiamine-responsive megaloblastic anemia syndrome","scopeLabel":"ORPHA:49827","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["05fabb311882fe9253d16741a3cb0906c9d0bb5e19d38633c5c25ef34aab365e","203a8b73b9ff1a554d60d055c6c13f29cc70f84f626849b45d766d195f2f511d","306216f86cc87f374f822361ba6ab0ddfd0af27970701e1b20955b386d9ecd32","362ffb30ffa472bd86b72c5d1fe6b0ad1b8457c20d7c41bacff8971098815a45","3d41c170df20375dfe376b136110a9407dedc2a78b9a481db08067b7adfca080","5bf5a720d5c6e729746e3bf5c443cc74adcfcacb00a95fbdb8c5417d81186226","65951c1fec184f057d18e51bbb228035e6f1705f92b5dee152da6276369afff8","6f4ff0e58d610be8b455d50f791f33ae581168548570d3289ffe4aa9d963c6a5","6fcdc3f1c7dd62a94fc2d723c6301f6ee45c2477ec553666ed51656831d20b6d","70ea4f8cca634f713f01ec573181d562e3d0f65eaa5a1b011e2cd0db2d516cc2","720bbcd1d39534519e1124243aaba8a33278ab561e1810e37177a7d7577bf2de","8e82042b198498a27f74384706666def15b33b3a362107cbdd362fad88570d7c","9160d955df0d2bb6915a5d72f36cd574afe61df3abd0f05198c5ebd022236f65","a3fd99f36556cd40ee64358faac4a7a5684dbaea638cfa111fcf54cd83ab5d62","b730ee55099e9484a717763baeed78ca0d7ae5a58cd639fd6e1e56ddc696ebb0","ba5192fa32aa4cb71599b77a936991f8150b53f54b754cd3bde39dcc62dda65f","d018b89d15411970cf845d5a9795a921cd4b2a6d2e68acc2743a7b9b17578945","d16cca05d7bfd3f04d9d85ae3f6d8aa0312792a5ffcce217c32644ddd75b9b4f","e2c9db034086b34492687b98cf92ebae668d6e869d203546793cd34a42f05c69","f87246ec00cd8fd2f28c3ac325e86d881c4bfe6fa0a447294865f5cc850984cf"],"recordQualifiers":{},"scopeLabel":"ORPHA:49827","sourceIds":["ORPHA:49827"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-181c482cfd8c7283975e","population-4317a783606bea20ef34"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000951","HP:0003355","HP:0002039","HP:0011675","HP:0001251","HP:0001631","HP:0001695"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":3,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":45,"sourceGroups":{"omim":22,"orphanet":20,"published":3}},"features":[{"hpoId":"HP:0000951","label":"Abnormality of the skin","primary":true},{"hpoId":"HP:0003355","label":"Aminoaciduria","primary":true},{"hpoId":"HP:0002039","label":"Anorexia","primary":true},{"hpoId":"HP:0011675","label":"Arrhythmia","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0001631","label":"Atrial septal defect","primary":true},{"hpoId":"HP:0001695","label":"Cardiac arrest","primary":true},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":false},{"hpoId":"HP:0000548","label":"Cone/cone-rod dystrophy","primary":false},{"hpoId":"HP:0001635","label":"Congestive heart failure","primary":false},{"hpoId":"HP:0000028","label":"Cryptorchidism","primary":false},{"hpoId":"HP:0000819","label":"Diabetes mellitus","primary":false},{"hpoId":"HP:0002014","label":"Diarrhea","primary":false},{"hpoId":"HP:0002020","label":"Gastroesophageal reflux","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0002315","label":"Headache","primary":false},{"hpoId":"HP:0001609","label":"Hoarse voice","primary":false},{"hpoId":"HP:0001254","label":"Lethargy","primary":false},{"hpoId":"HP:0001889","label":"Megaloblastic anemia","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0000980","label":"Pallor","primary":false},{"hpoId":"HP:0003401","label":"Paresthesia","primary":false},{"hpoId":"HP:0006671","label":"Paroxysmal atrial tachycardia","primary":false},{"hpoId":"HP:0000546","label":"Retinal degeneration","primary":false},{"hpoId":"HP:0000556","label":"Retinal dystrophy","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0000407","label":"Sensorineural hearing impairment","primary":false},{"hpoId":"HP:0004322","label":"Short stature","primary":false},{"hpoId":"HP:0001924","label":"Sideroblastic anemia","primary":false},{"hpoId":"HP:0001696","label":"Situs inversus totalis","primary":false},{"hpoId":"HP:0001297","label":"Stroke","primary":false},{"hpoId":"HP:0004860","label":"Thiamine-responsive megaloblastic anemia","primary":false},{"hpoId":"HP:0001873","label":"Thrombocytopenia","primary":false},{"hpoId":"HP:0001629","label":"Ventricular septal defect","primary":false},{"hpoId":"HP:0000572","label":"Visual loss","primary":false}],"ledeHtml":"Thiamine-responsive megaloblastic anemia syndrome (TRMA) is a rare condition that is characterized by hearing loss, diabetes, and a blood disorder called megaloblastic anemia. Megaloblastic anemia occurs when a person has a low number of red blood cells (anemia), and the red blood cells that are present are larger than normal (megaloblastic). The symptoms of this blood disorder may include decreased appetite, lack of energy, headaches, pale skin, diarrhea, and tingling or numbness in the hands and feet. Individuals with TRMA typically develop megaloblastic anemia between infancy and adolescence. TRMA is called &quot;thiamine-responsive&quot; because the anemia can be treated with daily doses of vitamin B1 (thiamine).","mondoId":"MONDO:0009575","node":{"canonicalSlug":"thiamine-responsive-megaloblastic-anemia","comparisons":[{"documentSha256":"3a0a19c5e00962ce6cd7d5f4a5ee017b91cc5df3b456688beab8f2f03bc2b123","key":"legacy-thiamine-responsive-megaloblastic-anemia","kind":"legacy","label":"thiamine-responsive megaloblastic anemia syndrome","memberIds":["MONDO:0009575"],"mondoId":"MONDO:0009575","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/thiamine-responsive-megaloblastic-anemia.3a0a19c5e00962ce6cd7d5f4a5ee017b91cc5df3b456688beab8f2f03bc2b123.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":["Variants (also called mutations) in the SLC19A2 gene cause TRMA. This gene provides instructions for making a protein called thiamine transporter 1, which transports thiamine into cells. Thiamine is found in many different foods and is important for numerous body functions.","Most variants in the SLC19A2 gene lead to the production of an abnormally short, nonfunctional version of thiamine transporter 1. Other variants change single protein building blocks (amino acids) in thiamine transporter 1. All of these variants disrupt the protein's ability to bring thiamine into the cell. TRMA is treated with daily doses of thiamine because some thiamine can pass into the cell without the help of a transporter when the vitamin is present in large amounts.","It remains unclear exactly how variants in the SLC19A2 gene cause the specific set of features seen in people with TRMA. Research suggests that an alternative transporter made by a different gene is available to transport thiamine in many tissues of the body. However, this alternative transporter may not be as active in the inner ear, the bone marrow (where blood cells are made), and the pancreas (where insulin is made), which would explain why these tissues are affected in people with TRMA."],"causesUrl":"https://medlineplus.gov/genetics/condition/thiamine-responsive-megaloblastic-anemia-syndrome/#causes","contentForm":"summary","matchMethod":"automatic-preferred-name","name":"Thiamine-responsive megaloblastic anemia syndrome","paragraphs":["Thiamine-responsive megaloblastic anemia syndrome (TRMA) is a rare condition that is characterized by hearing loss, diabetes, and a blood disorder called megaloblastic anemia. Megaloblastic anemia occurs when a person has a low number of red blood cells (anemia), and the red blood cells that are present are larger than normal (megaloblastic). The symptoms of this blood disorder may include decreased appetite, lack of energy, headaches, pale skin, diarrhea, and tingling or numbness in the hands and feet. Individuals with TRMA typically develop megaloblastic anemia between infancy and adolescence. TRMA is called \"thiamine-responsive\" because the anemia can be treated with daily doses of vitamin B1 (thiamine).","In people with TRMA, hearing loss typically develops during early childhood and is caused by abnormalities of the inner ear (sensorineural hearing loss). The hearing loss usually worsens over time. It remains unclear whether treatment with thiamine can improve hearing or delay hearing loss in people with TRMA.","People with TRMA often develop diabetes mellitus, a condition in which glucose levels can become dangerously high, at an early age. Although some individuals with TRMA develop diabetes during childhood, they do not have the autoimmune form of diabetes that typically develops in children, called type 1 diabetes. People with TRMA usually require insulin to treat their diabetes. In some cases, treatment with thiamine may delay the onset of diabetes or reduce the amount of insulin a person needs.","Some individuals with TRMA have abnormalities of the eye, including optic atrophy, which is the degeneration (atrophy) of the nerves that carry information from the eyes to the brain. Additional features of this condition may include heart and blood vessel (cardiovascular) problems, intellectual disabilities, behavioral changes, and seizures."],"reviewed":"2024-12","scope":"exact","scopeNote":"","source":"MedlinePlus","sourceRelease":"2026-10-01","upstream":"MedlinePlus Genetics","url":"https://medlineplus.gov/genetics/condition/thiamine-responsive-megaloblastic-anemia-syndrome"},"ownColumnKeys":["population-181c482cfd8c7283975e","population-4317a783606bea20ef34"],"publication":"published","relationships":[{"kind":"parent","label":"thiamine-responsive dysfunction syndrome","mondoId":"MONDO:0000152","slug":"thiamine-responsive-dysfunction"},{"kind":"parent","label":"autosomal recessive disease","mondoId":"MONDO:0006025","slug":null},{"kind":"parent","label":"vitamin B12- and folate-independent constitutional megaloblastic anemia","mondoId":"MONDO:0020112","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Name scope not exact or reviewed","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/9210"}],"translation":"pending","articles":[{"articleId":"www.ncbi.nlm.nih.gov/books/NBK1282","pageMondoId":"MONDO:0009575","source":"GeneReviews","name":"Thiamine-Responsive Megaloblastic Anemia Syndrome","url":"https://www.ncbi.nlm.nih.gov/books/NBK1282/","relationToPage":"same-condition","coveredMondoIds":["MONDO:0009575"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-preferred-title"],"reviewed":"2022-07-28","sourceRelease":"2026-10-18 12:07:37.803694+00","upstream":"GeneReviews clinical characteristics","rawAttribution":null,"independentCorroborationEstablished":false}]},"records":[{"frequencyKind":"reported","key":"02cc368270d114d5138eeed135628f794088d8e2cfcb47e9cfa0d49779cf339e","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001924","is_excluded":false,"label":"Sideroblastic anemia","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"05fabb311882fe9253d16741a3cb0906c9d0bb5e19d38633c5c25ef34aab365e","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000407","is_excluded":false,"label":"Sensorineural hearing impairment","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"08de078933bdc55458a682aa25087ecb8dc98c801915485bf358729b5d05beb4","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000548","is_excluded":false,"label":"Cone/cone-rod dystrophy","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"0b3aa54afc161b307cce11547e23653ea3b44b81e1db38d9bc19dc01a9fb8aa0","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000951","is_excluded":false,"label":"Abnormality of the skin","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"203a8b73b9ff1a554d60d055c6c13f29cc70f84f626849b45d766d195f2f511d","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001695","is_excluded":false,"label":"Cardiac arrest","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"2e2399d076fceb0b6de7c51e361db5e74b3602c3ee8f868be03715fc2687d918","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"306216f86cc87f374f822361ba6ab0ddfd0af27970701e1b20955b386d9ecd32","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001629","is_excluded":false,"label":"Ventricular septal defect","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"362ffb30ffa472bd86b72c5d1fe6b0ad1b8457c20d7c41bacff8971098815a45","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000980","is_excluded":false,"label":"Pallor","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3d41c170df20375dfe376b136110a9407dedc2a78b9a481db08067b7adfca080","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4199d3e33258f36b6b7c0aa8ff50663595b07a48ba3b3c639e8aec60dcf48b7c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"517a15d9675c25dfdf83f83f8f2d7505ad68266398eab48fdc4a2f26630ceb38","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0004860","is_excluded":false,"label":"Thiamine-responsive megaloblastic anemia","onset_id":null,"reference":"PMID:19643445","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"5717037e59ede80f457ed2dec33ea8037eaaf67c7b57cd98d45fd645c8721382","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001297","is_excluded":false,"label":"Stroke","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"596583379fdf929cd558852e295ddc1655171c3158e78ce4c233932734a015c1","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001638","is_excluded":false,"label":"Cardiomyopathy","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"5bf5a720d5c6e729746e3bf5c443cc74adcfcacb00a95fbdb8c5417d81186226","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002039","is_excluded":false,"label":"Anorexia","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"65951c1fec184f057d18e51bbb228035e6f1705f92b5dee152da6276369afff8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002315","is_excluded":false,"label":"Headache","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"6d15e2cba635fc179f9c61721e08a18f9865646cd3f190f806a47b7c62e55d41","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001631","is_excluded":false,"label":"Atrial septal defect","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"6f4ff0e58d610be8b455d50f791f33ae581168548570d3289ffe4aa9d963c6a5","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001254","is_excluded":false,"label":"Lethargy","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6fcdc3f1c7dd62a94fc2d723c6301f6ee45c2477ec553666ed51656831d20b6d","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000572","is_excluded":false,"label":"Visual loss","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"70ea4f8cca634f713f01ec573181d562e3d0f65eaa5a1b011e2cd0db2d516cc2","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"720bbcd1d39534519e1124243aaba8a33278ab561e1810e37177a7d7577bf2de","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003401","is_excluded":false,"label":"Paresthesia","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7e1be44564fd7c59984c22bd4c89179c5724583155798b7fde5d7a0335637d0e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"88003a0f51884e120a8fdc1c06906c71267d479d8315ef1cb961269fa9c607e8","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000572","is_excluded":false,"label":"Visual loss","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"8b3ff74793e75403d817c5cc33d1900bfeeaac8ada073704595cd9c9068ef6fa","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"8e82042b198498a27f74384706666def15b33b3a362107cbdd362fad88570d7c","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001635","is_excluded":false,"label":"Congestive heart failure","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9160d955df0d2bb6915a5d72f36cd574afe61df3abd0f05198c5ebd022236f65","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001889","is_excluded":false,"label":"Megaloblastic anemia","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"995d7fb19973de4165c0608ca09517f2c4e80977119f894c4d4faf1a11dd07d2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003355","is_excluded":false,"label":"Aminoaciduria","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"9a5e716c827828c5aa94dd3b4bcd6f64b3e70ca7130ff80c99b34172a6253716","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"9cb291f403a2cc921ab2278844ac471edb3bc20666d068607d818ebcf663e419","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000546","is_excluded":false,"label":"Retinal degeneration","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"a3fd99f36556cd40ee64358faac4a7a5684dbaea638cfa111fcf54cd83ab5d62","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"b1ec2921e07ff4fa3436a326061e130a4787c665e320aa29263c952523eaf49d","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001609","is_excluded":false,"label":"Hoarse voice","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"b6364380e06314232187a0670c597479ab28ca9c9ddfe4d3bbe841383c306bf8","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011675","is_excluded":false,"label":"Arrhythmia","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"b730ee55099e9484a717763baeed78ca0d7ae5a58cd639fd6e1e56ddc696ebb0","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000819","is_excluded":false,"label":"Diabetes mellitus","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ba5192fa32aa4cb71599b77a936991f8150b53f54b754cd3bde39dcc62dda65f","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000556","is_excluded":false,"label":"Retinal dystrophy","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"bda78c4be3dbd27d00bd233eb29d0c5e594e28fbb22257ff82b6b804400a3134","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001629","is_excluded":false,"label":"Ventricular septal defect","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"cd6234c8b39b1b6cf842c598767c7fa88c6c9c683d3c67a1527fa61080dd33d2","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002020","is_excluded":false,"label":"Gastroesophageal reflux","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"d018b89d15411970cf845d5a9795a921cd4b2a6d2e68acc2743a7b9b17578945","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001297","is_excluded":false,"label":"Stroke","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d16cca05d7bfd3f04d9d85ae3f6d8aa0312792a5ffcce217c32644ddd75b9b4f","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0006671","is_excluded":false,"label":"Paroxysmal atrial tachycardia","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"d8de297a6603083c6c176b373da825590d9f5d7dcf51011e6918f1d129c25ecc","raw":{"aspect":"P","body_system":"ear","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"PCS","frequency_raw":"6/7","hpo_id":"HP:0000407","is_excluded":false,"label":"Sensorineural hearing impairment","onset_id":null,"reference":"PMID:19643445","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"e2c9db034086b34492687b98cf92ebae668d6e869d203546793cd34a42f05c69","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001631","is_excluded":false,"label":"Atrial septal defect","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"e32ceeb914244b320a11e77700dc2aad8fb6f830f0faa7af70534da095b3428c","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"PCS","frequency_raw":"7/7","hpo_id":"HP:0000819","is_excluded":false,"label":"Diabetes mellitus","onset_id":null,"reference":"PMID:19643445","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"f58f1dbf44bbf760aa971440c29be59ae0b84eef6455ffb93cc746aaa0adeded","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f637ad29780f6035f211ce17a2b3ccbe515559a52fb935f92181815736015f2c","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001696","is_excluded":false,"label":"Situs inversus totalis","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"f66412a9c94f73d6fa3368c7bd66c2ce08bcff07711aef6ec0b21be68c962953","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f763d1f3913469e15ca28cbc9a7adbada1a71dc9c6a52ccd75209a5f51ec590e","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:249270","disease_name":"Thiamine-Responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000028","is_excluded":false,"label":"Cryptorchidism","onset_id":null,"reference":"OMIM:249270","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f87246ec00cd8fd2f28c3ac325e86d881c4bfe6fa0a447294865f5cc850984cf","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:49827","disease_name":"Thiamine-responsive megaloblastic anemia syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002014","is_excluded":false,"label":"Diarrhea","onset_id":null,"reference":"ORPHA:49827","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/thiamine-responsive-megaloblastic-anemia-syndrome\" rel=\"noreferrer\">MedlinePlus</a></p><p class=\"section-source\">Source: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK1282/\" rel=\"noreferrer\">GeneReviews</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009575\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-name</dd><dt>Upstream attribution</dt><dd>MedlinePlus Genetics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Thiamine-responsive megaloblastic anemia syndrome (TRMA) is a rare condition that is characterized by hearing loss, diabetes, and a blood disorder called megaloblastic anemia. Megaloblastic anemia occurs when a person has a low number of red blood cells (anemia), and the red blood cells that are present are larger than normal (megaloblastic). The symptoms of this blood disorder may include decreased appetite, lack of energy, headaches, pale skin, diarrhea, and tingling or numbness in the hands and feet. Individuals with TRMA typically develop megaloblastic anemia between infancy and adolescence. TRMA is called &quot;thiamine-responsive&quot; because the anemia can be treated with daily doses of vitamin B1 (thiamine).</p><p>In people with TRMA, hearing loss typically develops during early childhood and is caused by abnormalities of the inner ear (sensorineural hearing loss). The hearing loss usually worsens over time. It remains unclear whether treatment with thiamine can improve hearing or delay hearing loss in people with TRMA.</p><p>People with TRMA often develop diabetes mellitus, a condition in which glucose levels can become dangerously high, at an early age. Although some individuals with TRMA develop diabetes during childhood, they do not have the autoimmune form of diabetes that typically develops in children, called type 1 diabetes. People with TRMA usually require insulin to treat their diabetes. In some cases, treatment with thiamine may delay the onset of diabetes or reduce the amount of insulin a person needs.</p><p>Some individuals with TRMA have abnormalities of the eye, including optic atrophy, which is the degeneration (atrophy) of the nerves that carry information from the eyes to the brain. Additional features of this condition may include heart and blood vessel (cardiovascular) problems, intellectual disabilities, behavioral changes, and seizures.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/thiamine-responsive-megaloblastic-anemia-syndrome\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"overview","title":"Overview"},{"bodyHtml":"<p>Variants (also called mutations) in the SLC19A2 gene cause TRMA. This gene provides instructions for making a protein called thiamine transporter 1, which transports thiamine into cells. Thiamine is found in many different foods and is important for numerous body functions.</p><p>Most variants in the SLC19A2 gene lead to the production of an abnormally short, nonfunctional version of thiamine transporter 1. Other variants change single protein building blocks (amino acids) in thiamine transporter 1. All of these variants disrupt the protein&#x27;s ability to bring thiamine into the cell. TRMA is treated with daily doses of thiamine because some thiamine can pass into the cell without the help of a transporter when the vitamin is present in large amounts.</p><p>It remains unclear exactly how variants in the SLC19A2 gene cause the specific set of features seen in people with TRMA. Research suggests that an alternative transporter made by a different gene is available to transport thiamine in many tissues of the body. However, this alternative transporter may not be as active in the inner ear, the bone marrow (where blood cells are made), and the pancreas (where insulin is made), which would explain why these tissues are affected in people with TRMA.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/thiamine-responsive-megaloblastic-anemia-syndrome/#causes\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"causes","title":"Causes"}],"sharedSources":[],"slug":"thiamine-responsive-megaloblastic-anemia","sourceDocuments":[{"name":"MedlinePlus: Thiamine-responsive megaloblastic anemia syndrome","reviewed":"2024-12","source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/thiamine-responsive-megaloblastic-anemia-syndrome"},{"name":"GeneReviews: Thiamine-Responsive Megaloblastic Anemia Syndrome","reviewed":"2022-07-28","source_release":"2026-10-18 12:07:37.803694+00","url":"https://www.ncbi.nlm.nih.gov/books/NBK1282/"},{"name":"MONDO: thiamine-responsive megaloblastic anemia syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009575"}],"sourceNote":"","synonyms":["megaloblastic anaemia thiamine-responsive with diabetes mellitus and sensorineural deafness","megaloblastic anemia thiamine-responsive with diabetes mellitus and sensorineural deafness","Rogers syndrome","thiamine metabolism dysfunction syndrome 1","thiamine responsive megaloblastic anaemia syndrome","thiamine responsive megaloblastic anemia syndrome","thiamine-responsive Anaemia syndrome","thiamine-responsive anemia syndrome","thiamine-responsive megaloblastic anemia syndrome","thiamine-responsive megaloblastic anemia with diabetes mellitus and sensorineural deafness","thiamine-responsive myelodysplasia","THMD1","TRMA"],"takeawayHtml":"","title":"thiamine-responsive megaloblastic anemia syndrome"},"schemaVersion":1}
